Journal of Affective Disorders (J AFFECT DISORDERS )

Publisher: International Society for Affective Disorders, Elsevier

Description

The Journal of Affective Disorders publishes papers concerned with affective disorders in the widest sense: depression, mania, anxiety and panic. It is interdisciplinary and aims to bring together different approaches for a diverse readership. High quality papers will be accepted dealing with any aspect of affective disorders, including biochemistry, pharmacology, endocrinology, genetics, statistics, epidemiology, psychodynamics, classification, clinical studies and studies of all types of treatment.

  • Impact factor
    3.30
    Show impact factor history
     
    Impact factor
  • 5-year impact
    3.86
  • Cited half-life
    6.10
  • Immediacy index
    0.65
  • Eigenfactor
    0.04
  • Article influence
    1.13
  • Website
    Journal of Affective Disorders website
  • Other titles
    Journal of affective disorders (Online)
  • ISSN
    0165-0327
  • OCLC
    38911953
  • Material type
    Document, Periodical, Internet resource
  • Document type
    Internet Resource, Computer File, Journal / Magazine / Newspaper

Publisher details

Elsevier

  • Pre-print
    • Author can archive a pre-print version
  • Post-print
    • Author can archive a post-print version
  • Conditions
    • Voluntary deposit by author of pre-print allowed on Institutions open scholarly website and pre-print servers
    • Voluntary deposit by author of authors post-print allowed on institutions open scholarly website including Institutional Repository
    • Deposit due to Funding Body, Institutional and Governmental mandate only allowed where separate agreement between repository and publisher exists
    • Set statement to accompany deposit
    • Published source must be acknowledged
    • Must link to journal home page or articles' DOI
    • Publisher's version/PDF cannot be used
    • Articles in some journals can be made Open Access on payment of additional charge
    • NIH Authors articles will be submitted to PMC after 12 months
    • Authors who are required to deposit in subject repositories may also use Sponsorship Option
    • Pre-print can not be deposited for The Lancet
  • Classification
    ​ green

Publications in this journal

  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Previous resting-state electroencephalography studies have consistently shown that lithium enhances delta and theta oscillations in default mode networks. Cognitive task based networks differ from resting-state networks and this is the first study to investigate effects of lithium on evoked and event-related beta oscillatory responses of patients with bipolar disorder. Methods: The study included 16 euthymic patients with bipolar disorder on lithium monotherapy, 22 euthymic medication-free patients with bipolar disorder and 21 healthy participants. The maximum peak-to-peak amplitudes were measured for each subject's averaged beta responses (14-28 Hz) in the 0-300 ms time window. Auditory simple and oddball paradigm were presented to obtain evoked and event-related beta oscillatory responses. Results: There were significant differences in beta oscillatory responses between groups (p=0.010). Repeated measures ANOVA revealed location (p=0.007), lateralityXgroup (p=0.043) and stimulusXlocation (p=0.013) type effects. Serum lithium levels were correlated with beta responses. Limitations: The lithium group had higher number of previous episodes, suggesting that patients of the lithium were more severe cases than patients of the medication-free group. Discussion: Lithium stimulates neuroplastic cascades and beta oscillations become prominent during neuroplastic changes. Excessively enhanced beta oscillatory responses in the lithium-treated patients may be indicative of excessive activation of the neuron groups of the certain cognitive networks and dysfunctional GABAergic modulation during cognitive activity.
    Journal of Affective Disorders 01/2015;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Despite treatment guidelines for depression placing group cognitive behavioral therapy (group CBT) between low- and high-intensity evidence-based psychological interventions, the validity of the placement remains unknown. We aimed to systematically review evidence for the efficacy and acceptability of group CBT in patients with depression compared to four intensity levels of psychosocial interventions.
    Journal of Affective Disorders 08/2014; 164:155-164.
  • Journal of Affective Disorders 07/2014;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Recentstudiesindicatethatchoiceofprofessionisrelatedtodifferencesinaffective temperament,whichisprobablyduetovariouspredispositionsneededtoefficiently performparticular professions. Theaimofthepresentstudywastoassessaffectivetemperamentandexecutivefunctionsin a sampleofemergencymedicineprofessionals. Methods: 75 emergencymedicineprofessionalswereenrolledinthestudy.Affectivetemperamentwas assessed bymeansofTEMPS-A.ExecutivefunctionswereassessedbymeansofTrailMakingTestand StroopColorWordInterferenceTest. Results: Subjects showedsignificantly higherratesofhyperthymic,comparedtodepressive,cyclothymic, irritable andanxioustemperaments.Theprincipalcomponentanalysisrevealedthathyperthymic temperamentcontributestoadifferentfactor,thantheremainingones.Higherratesofdepressive, cyclothymic,irritableandanxioustemperamentswererelatedtopoorerperformanceinTrailMaking Test,whereashyperthymictemperamenthadtheoppositeeffect. Limitations: Due tothesizeofthesample,resultsofthepresentstudymayhavelackedpowertoshowall the relationshipsbetweentestedvariables. Conclusions: Hyperthymictemperamentpromotesefficient performanceofcomplextasksundertime pressure.Depressive,cyclothymic,irritableandanxioustemperamentshavetheoppositeeffect.This makes hyperthymictemperamentadesirabletraitinemergencymedicineprofessionals,performing complexmedicaltasksunderextremeconditions.
    Journal of Affective Disorders 07/2014; 168(2014):192-196.
  • Journal of Affective Disorders 07/2014; 163:40-46.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Several lines of evidence suggest that neuroplasticity is impaired in depression and improves with effective treatment. However until now, this evidence has largely involved measures such as learning and memory which can be influenced by subject effort and motivation. This pilot study aimed to objectively measure neuroplasticity in the motor cortex using paired associative stimulation (PAS), which induces short term neuroplastic changes. It is hypothesized that neuroplasticity would improve after effective treatment for depression. Methods Neuroplasticity was measured in 18 depressed subjects before and after a course of anodal transcranial direct current stimulation (tDCS), given as treatment for depression. The relationships between PAS results, mood state and brain-derived neurotrophic factor (BDNF) serum levels were examined. Results Neuroplasticity (PAS-induced change) was increased after a course of tDCS (t(17)=−2.651, p=0.017). Treatment with tDCS also led to significant mood improvement, but this did not correlate with improved neuroplasticity. Serum BDNF levels did not change after tDCS, or correlate with change in neuroplasticity after tDCS treatment. Limitations While this study showed evidence of improved neuroplasticity in the motor cortex after effective treatment, we are unable to present evidence that this change is generalized in the depressed brain. Also, the presence of antidepressant medications and the small sample of patients (n=18) meant the study could not definitively resolve the relationship between neuroplasticity, mood and BDNF. Conclusion This novel preliminary study provides evidence that a treatment course of tDCS can improve neuroplasticity in depressed patients.
    Journal of Affective Disorders 06/2014; 167:140-147.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Both individuals with bipolar (BD) and those with alcohol (AUD) and other substance (SUD) use disorders are likely to attempt suicide. Comorbidity of BD and AUD/SUD may increase the likelihood of suicide attempts. We conducted a meta-analysis to estimate the association of comorbid AUD/SUD and suicide attempts in subjects with BD in the literature to date. Methods: Electronic databases through January 2013 were searched. Studies reporting rates of suicide attempts in people with co-occurring BD and AUD/SUD were retrieved. Comorbid AUD and SUD and suicide attempts rates as well as demographic, clinical, and methodological variables were extracted from each publication or obtained directly from its authors. Results: Twenty-nine of 222 studies assessed for eligibility met the inclusion criteria, comprising a total of 31,294 individuals with BD, of whom 6,308 (20.1%) had documented suicide attempts. There were consistent findings across the studies included. As compared to controls, subjects with BD and comorbid AUD/SUD were more likely to attempt suicide. The cross-sectional association estimates showed random-effects pooled crude ORs of 1.96 (95%CI=1.56-2.47; p<0.01), 1.72 (95% CI=1.52-1.95; p<0.01), and 1.77 (95%CI=1.49-2.10; p<0.01), for combined AUD/SUD, AUD, and SUD. There was no publication bias and sensitivity analyses based on the highest quality studies confirmed core results. Limitations: The effects of the number and the type of suicide attempts could not be investigated due to insufficient information. Conclusions: Comorbid AUD and SUD in individuals with BD are significantly associated with suicide attempts. Individuals with this comorbidity should be targeted for intensive suicide prevention efforts.
    Journal of Affective Disorders 06/2014; 167:125-135.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background To 1) establish the lifetime and 12-month prevalence of DSM-5 bipolar and related disorders including the new algorithmically defined conditions grouped within Other Specified Bipolar and Related Disorders (OSBARD) as well as hyperthymic personality in a randomly selected community sample, and 2) determine the clinical relevance of the OSBARD category in terms of sociodemographic characteristics, course, comorbidity and treatment patterns by comparing the subjects of this category to those with bipolar-I (BP-I), bipolar-II (BP-II), major depressive disorder (MDD), and those with no history of mood disorders. Methods The semi-structured Diagnostic Interview for Genetic Studies was administered by masterslevel psychologists to a random sample of an urban area (n=3′719). Results The lifetime prevalence was 1.0% for BP-I, 0.8% for BP-II, 1.0% for OSBARD and 3% for hyperthymic personality. Subjects with OSBARD were more severely affected than subjects without a history of mood disorders regarding almost all clinical correlates. Compared to those with MDD, they also revealed an elevated risk of suicidal attempts, lower global functioning, more treatment seeking and more lifetime comorbidity including anxiety, substance use and impulse-control disorders. However, they did not differ from subjects with BP-II. Limitations Small sample sizes for bipolar and related disorders and potential inaccurate recall of symptoms. Conclusions The modifications of diagnostic criteria for manic/hypomanic episodes according to the DSM-5 only marginally affect the prevalence estimates for BP-I and BP-II. The new DSM-5 OSBARD category is associated with significant clinical burden, is hardly distinct from BP-II with respect to clinical correlates and deserves similar clinical attention.
    Journal of Affective Disorders 06/2014; 167:198–205.

Related Journals